After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Johnson & Johnson is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Johnson & Johnson is $509.76B. A total of 6.87 million shares were traded on the day, compared to an average of 8.86M shares.
In the most recent transaction, MORIKIS JOHN G bought 1,250 shares of JNJ for 206.15 per share on Nov 26 ’25. After the transaction, the Director now owns 1,849 company shares. In a previous transaction on Nov 26 ’25, JOHNSON & JOHNSON sold 6,337 shares at 10.03 per share. JNJ shares that 10% Owner owns now total 4,040,861.
Among the insiders who sold shares, JOHNSON & JOHNSON disposed of 2,200 shares on Nov 24 ’25 at a per-share price of $10.06. This resulted in the 10% Owner holding 4,047,198 shares of JNJ after the transaction. In another insider transaction, JOHNSON & JOHNSON sold 500 shares at $10.00 per share on Nov 21 ’25. Company shares held by the 10% Owner now total 4,049,398.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Johnson & Johnson pays an annual dividend of $5.14, resulting in a dividend yield of 2.43%, and it has a price to earnings (P/E) ratio of 20.42.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, JNJ has a high of $211.24 and a low of $140.68.
As of this writing, JNJ has an earnings estimate of $2.53 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of $2.58 per share and a lower estimate of $2.47. The company reported an EPS of $2.04 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $32.95, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 4.12.
